Nucleic acid encoding rat galanin receptor (GALR2)
US6287855A · kind A · utility
1Cited by
1References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 18, 1997 |
| Grant date | Sep 11, 2001 |
| Priority date | — |
| Expiry date | Dec 18, 2017 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/72
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A new galanin receptor, GALR2, is described. Also provided are nucleic acids encoding same and various assays to identify ligands particular to said receptor. Ligands so identified are useful for the treatment of obesity, treatment of pain, and treatment of cognitive disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.